0.3617

2.27% -0.0084

After Hours: .35 -0.0117 -3.23%

Werewolf Therapeutics Inc (HOWL)

Overview News Price History Option Chain Financials Discussions Forecast

Werewolf Therapeutics Inc stock is traded at $0.3617, with a volume of 515.59K. It is down -2.27% in the last 24 hours and down -18.46% over the past month. Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Previous Close:

$0.3701

Open:

$0.3701

24h Volume:

515.59K

Relative Volume:

1.02

Market Cap:

$17.58M

Revenue:

$1.14M

Net Income/Loss:

$-56.27M

P/E Ratio:

-0.298

EPS:

-1.2139

Net Cash Flow:

$-51.94M

1W Performance:

+0.47%

1M Performance:

-18.46%

6M Performance:

-42.47%

1Y Performance:

-71.06%

1-Day Range:

$0.3584

$0.38

1-Week Range:

$0.338

$0.4067

52-Week Range:

$0.338

$2.38

Werewolf Therapeutics Inc Stock (HOWL) Company Profile

Name

Werewolf Therapeutics Inc

Sector

Healthcare (1102)

Industry

Biotechnology (619)

Phone

617-952-0555

Address

200 TALCOTT AVENUE, WATERTOWN

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

HOWL's Discussions on Twitter

Compare HOWL vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOWL Werewolf Therapeutics Inc	0.3617	17.07M	1.14M	-56.27M	-51.94M	-1.2139
VRTX Vertex Pharmaceuticals Inc	468.42	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	618.03	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	853.40	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	288.18	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	169.51	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-25	Downgrade	Wedbush	Outperform → Neutral
Apr-03-24	Initiated	JMP Securities	Mkt Outperform
Aug-24-23	Initiated	Wedbush	Outperform
Jun-06-23	Resumed	Jefferies	Buy
Sep-10-21	Initiated	BofA Securities	Buy
May-25-21	Initiated	Evercore ISI	Outperform
May-25-21	Initiated	H.C. Wainwright	Buy
May-25-21	Initiated	Jefferies	Buy
May-25-21	Initiated	SVB Leerink	Outperform

View All

Werewolf Therapeutics Inc Stock (HOWL) Latest News

Jun 22, 2026

Ra Capital sells $145,918 of Werewolf Therapeutics (HOWL) stock By Investing.com - Investing.com Australia

Jun 22, 2026

Ra Capital sells $145,918 of Werewolf Therapeutics (HOWL) stock - Investing.com UK

Jun 22, 2026

[SCHEDULE 13D/A] Werewolf Therapeutics, Inc. Amended Major Shareholder Report - Stock Titan

Jun 22, 2026

Form 4 Werewolf Therapeutics Inc For: 22 June By Investing.com - Investing.com Nigeria

Jun 22, 2026

RA Capital funds trim Werewolf Therapeutics (HOWL) stake with 416,911-share sale - Stock Titan

Jun 22, 2026

Jun 19, 2026

RA Capital Management Reduces Stake in Werewolf Therapeutics Inc - GuruFocus

Jun 19, 2026

Jun 18, 2026